# The Benefit of Add On DLBS1033 for Ischemic Stroke Patient

Study · id `cardio:ct-nct04425590` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04425590](<https://clinicaltrials.gov/study/NCT04425590>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04425590

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 180 participants.

## Technical summary

Registry record NCT04425590. Randomized; no masking; primary purpose supportive care. Start 2020-04-01 (actual); primary completion 2020-08 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose supportive care
- Phase: Phase 2/3
- Enrolled: 180 participants (planned count; ClinicalTrials.gov record NCT04425590, source copy `cardio:ctgov-nct04425590-2020-06-11`, retrieved 2026-10-26)
- Started: 2020-04-01 (actual) (ClinicalTrials.gov record NCT04425590, source copy `cardio:ctgov-nct04425590-2020-06-11`, retrieved 2026-10-26)
- Primary completion: 2020-08 (anticipated) (ClinicalTrials.gov record NCT04425590, source copy `cardio:ctgov-nct04425590-2020-06-11`, retrieved 2026-10-26)
- Completion: 2020-08 (anticipated) (ClinicalTrials.gov record NCT04425590, source copy `cardio:ctgov-nct04425590-2020-06-11`, retrieved 2026-10-26)
- Countries: Indonesia (ClinicalTrials.gov record NCT04425590, source copy `cardio:ctgov-nct04425590-2020-06-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04425590-2020-06-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Benefit of Add On DLBS1033 for Ischemic Stroke Patient
- Condition: Ischemic Stroke
- Intervention (Drug): DLBS1033
- Intervention (Drug): Aspirin
- Intervention (Drug): Statin
- Intervention (Drug): Vit B12
- Lead sponsor: Duta Wacana Christian University
- Lead sponsor class: OTHER
- Collaborator: Dexa Laboratories Of Biomolecular Science
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)

## Provenance

Content hash: e4364ac89633b3399b0d4ce6770bca2d4edbd894ac5e9b9b1508754833381317
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
